Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy

Annette Orleth, Christoph Mamot, Christoph Rochlitz, Reto Ritschard, Kari Alitalo, Gerhard Christofori, Andreas Wicki

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Alkuperäiskielienglanti
LehtiJournal of Drug Targeting
Vuosikerta24
Numero1
Sivut80-89
Sivumäärä10
ISSN1061-186X
DOI - pysyväislinkit
TilaJulkaistu - 2 tammikuuta 2016
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

  • 317 Farmasia
  • 3111 Biolääketieteet

Lainaa tätä

Orleth, Annette ; Mamot, Christoph ; Rochlitz, Christoph ; Ritschard, Reto ; Alitalo, Kari ; Christofori, Gerhard ; Wicki, Andreas. / Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy. Julkaisussa: Journal of Drug Targeting. 2016 ; Vuosikerta 24, Nro 1. Sivut 80-89.
@article{9dd896f93ef54406a9b923a9ad881022,
title = "Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy",
keywords = "Anti-angiogenic therapy, nanoparticle, targeted drug delivery, VEGFR2, VEGFR3, OVEREXPRESSING TUMOR-CELLS, LUNG-CANCER, GROWTH, ANGIOGENESIS, DOXORUBICIN, RESISTANCE, EXPRESSION, CHALLENGES, LIPOSOMES, INVASION, 317 Pharmacy, 3111 Biomedicine",
author = "Annette Orleth and Christoph Mamot and Christoph Rochlitz and Reto Ritschard and Kari Alitalo and Gerhard Christofori and Andreas Wicki",
year = "2016",
month = "1",
day = "2",
doi = "10.3109/1061186X.2015.1056189",
language = "English",
volume = "24",
pages = "80--89",
journal = "Journal of Drug Targeting",
issn = "1061-186X",
publisher = "Informa healthcare",
number = "1",

}

Orleth, A, Mamot, C, Rochlitz, C, Ritschard, R, Alitalo, K, Christofori, G & Wicki, A 2016, 'Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy', Journal of Drug Targeting, Vuosikerta 24, Nro 1, Sivut 80-89. https://doi.org/10.3109/1061186X.2015.1056189

Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy. / Orleth, Annette; Mamot, Christoph; Rochlitz, Christoph; Ritschard, Reto; Alitalo, Kari; Christofori, Gerhard; Wicki, Andreas.

julkaisussa: Journal of Drug Targeting, Vuosikerta 24, Nro 1, 02.01.2016, s. 80-89.

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

TY - JOUR

T1 - Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy

AU - Orleth, Annette

AU - Mamot, Christoph

AU - Rochlitz, Christoph

AU - Ritschard, Reto

AU - Alitalo, Kari

AU - Christofori, Gerhard

AU - Wicki, Andreas

PY - 2016/1/2

Y1 - 2016/1/2

KW - Anti-angiogenic therapy

KW - nanoparticle

KW - targeted drug delivery

KW - VEGFR2

KW - VEGFR3

KW - OVEREXPRESSING TUMOR-CELLS

KW - LUNG-CANCER

KW - GROWTH

KW - ANGIOGENESIS

KW - DOXORUBICIN

KW - RESISTANCE

KW - EXPRESSION

KW - CHALLENGES

KW - LIPOSOMES

KW - INVASION

KW - 317 Pharmacy

KW - 3111 Biomedicine

U2 - 10.3109/1061186X.2015.1056189

DO - 10.3109/1061186X.2015.1056189

M3 - Article

VL - 24

SP - 80

EP - 89

JO - Journal of Drug Targeting

JF - Journal of Drug Targeting

SN - 1061-186X

IS - 1

ER -